BRCA2 and breast cancer: This standard includes, among others, referral of all patients with BC (diagnosed <40 years) and/or OVC (<60 years) for comprehensive genetic testing of at least BRCA1, BRCA2 and Tp53 by means of NGS, and decreasing the time to presentation, diagnosis and treatment.